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Abstract 
Extracorporeal membrane oxygenation is rapidly becoming a preferred therapy for 
short-term hemodynamic support in cardiogenic shock, along with the use of 
devices such as Impella (Abiomed, Andover, MA). The two together can create 
unique hemodynamics resulting in altered presentation of common hemodynamic 
conditions such as tamponade. We present a case of a patient with fulminant 
myocarditis requiring veno-arterial extracorporeal membrane oxygenation and 
Impella support. The patient later developed a pericardial effusion with atypical 
tamponade physiology, which masked the left ventricular systolic function 
recovery. We further highlight the complex hemodynamics of cardiac tamponade 
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Background 
Although extracorporeal membrane oxygenation (ECMO) has been available for 
over 40 years, used primarily in neonatology, over the past decade the technology 
has gained momentum in adult cardiology. ECMO is fast becoming a preferred 
device for short-term hemodynamic support in patients with cardiogenic shock, as 
seen by the exponential growth in the number of ECMO centers which has 
increased by 133% in the last decade.1 
Early use of veno-arterial ECMO (V-A ECMO) has shown the promising trend of 
increased survival in patients with fulminant myocarditis presenting with 
cardiogenic shock .2-5 A common drawback of this modality is an increase in left 
ventricular (LV) afterload, resulting in delayed myocardial recovery, pulmonary 
congestion, and other adverse sequalae. Several interventions can be used in 
conjugation with V-A ECMO to unload the LV, thereby avoiding complications .6,7 
One of the options of venting the LV is facilitating the forward flow with another 
device such as Impella (Abiomed, Andover, MA). The combination of two means of 
mechanical circulatory support (MCS) creates new hemodynamic patterns which 
may alter the presentation of common hemodynamic conditions such as 
tamponade. We describe a case of a young patient presenting with fulminant 
myocarditis leading to cardiogenic shock who was treated with a combination of V-
A ECMO and Impella (ECPELLA). The patient developed pericardial effusion with 
atypical tamponade physiology which masked the recovery of LV systolic function. 
We have also highlighted the complex hemodynamics of cardiac tamponade in a 




A 25-year-old, previously healthy female presented to the emergency room with a 
four-day history of nausea, vomiting, abdominal and central chest pain, and a fever 
of up to 102 °F. She developed ventricular tachycardia, cardiac arrest, and 
underwent cardiopulmonary resuscitation with return of spontaneous circulation in 
less than two minutes. The patient was intubated for airway protection. Her 
echocardiogram showed an LV ejection fraction (LVEF) of less than 10%. As she 
remained in cardiogenic shock, she was placed on V-A ECMO and Impella CP 
support. The ECMO flow was 4.5 L/min at a speed of 3590 revolutions per minute, 
and the Impella flow was 2.5 L/min at P6. The patient was also on epinephrine 
(0.05 mcg/kg/min) and milrinone (0.25 mcg/kg/min).  
On Day 2 of the patient’s hospitalization, her echocardiogram showed moderate 
pericardial effusion without any echocardiographic features of cardiac tamponade 
such as right ventricular or right atrial collapse, plethoric inferior vena cava, or 
excessive mitral/tricuspid inflow variability (Figure 1).  
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Figure 1: Transthoracic echocardiogram 4-chamber view prior to pericardial 
drainage (Video 1). 
Although unclear, the etiology of pericardial effusion could be due to viral 
myopericarditis or ventricular perforation during placement of the Impella CP. The 
patient’s blood pressure on Day 2 was 74/69 mmHg. The patient underwent right 
heart catheterization and endomyocardial biopsy. Percutaneous drainage of 
pericardial effusion was attempted, but unsuccessful.  
The patient’s right heart pressures were as follows:  right atrium 8 mmHg, right 
ventricle 29/3/7 mmHg, pulmonary artery 21/12 mmHg, pulmonary capillary wedge 
pressure 11 mmHg. The patient’s vasopressor requirement was increasing, with 
addition of vasopressin at 0.04 units/min. It was decided to drain the pericardial 
effusion surgically. The transesophageal echocardiography showed large 
pericardial effusion with floating of the heart with an estimated LVEF of around 
15% (Figures 2). During the drainage there was an immediate gush of blood 
suggesting high intra pericardial pressure. The pericardial fluid was sanguineous, 
and a clot was also removed. Echocardiography showed a mild improvement of LV 
systolic function (Figures 3 and 4).  
 
 
Figure 2. Transesophageal echocardiogram (transgastric view) showing the 
significant pericardial effusion build-up. A. Papillary muscle level B (Video 2A). 
Apex of the heart (Video 2B). 
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Figure 3. Transesophageal echocardiogram showing slight improvement in left 











Figure 4. Transthoracic echocardiogram the next day after pericardial effusion 
drainage, now with improving left ventricular function (Video 4). 
There was no immediate change in ECMO or Impella flow post-drainage; however, 
hemodynamics improved significantly with decreasing pressor requirements 
approximately 6 hours post-drainage. Epinephrine and vasopressin were reduced 
to 0.02 mcg/kg/min and 0.03 units/min, respectively. The patient was off 
vasopressin 24 hours post-drainage.  
The pericardial fluid showed mesothelial and mixed inflammatory cells, blood, and 
fibrin. The patient’s cardiac biopsy was consistent with acute lymphocytic 
myocarditis. The patient tested positive for SARS-CoV-2 and was treated with 
remdesivir (5-day course), high-dose methylprednisolone (3-day course), and 
convalescent plasma (2 doses). There was impressive recovery of LV function the 
next day. The patient made a complete recovery and was discharged home in less 
than 2 weeks. 
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Discussion 
In this case report, we describe a patient who became hemodynamically unstable 
while being supported on both V-A ECMO and Impella, which lead to a suspicion 
of cardiac tamponade. Although no clinical or echocardiographic signs of 
tamponade were present, the drainage of pericardial fluid resulted in immediate 
hemodynamic stabilization, confirming the diagnosis of tamponade. 
The classical Beck triad, described in 1935, remains the mainstay of our 
understanding and clinical diagnosis of pericardial tamponade. The triad consists 
of three medical signs including low blood pressure, distended neck veins, and 
muffled heart sounds, with the main pathophysiological phenomena of increased 
central venous pressure.8 Paradoxically, in a patient where ECMO is working 
optimally, blood pressure is usually maintained or artificially supported by 
vasopressors, central venous pressure is within normal limits, and heart sounds 
are replaced by machinery hum. Pulsus paradoxus, another cornerstone of 
physical exam-based diagnosis of tamponade, is no longer present. Pulsus 
paradoxus reflects decreased systolic output on inspiration while the right 
ventricular filling increases because of increased interventricular dependence. In a 
patient supported by V-A ECMO and Impella, forward flow is much less dependent 
on the ventricular filling/contraction and is mostly determined by ECMO and 
Impella, both providing a continuous (non-pulsatile) flow. This unique physiology of 
a mechanically supported patient can mask the presentation of acute cardiac 
tamponade, which is difficult to diagnose or even suspect if the traditional bed side 
teaching principles are applied in an ECMO patient. 
It is commonly said that tamponade is a clinical diagnosis; however, in reality, 
echocardiographic signs often precede the clinical signs. This is especially true in 
the intensive care setting in patients who are sedated, on a ventilator, and unable 
to report any symptoms. Echocardiography is the test of choice when the 
diagnosis of tamponade is clinically suspected. Significant progress and 
standardization has been made especially in Doppler interpretation of cardiac 
tamponade physiology, the hallmark of which is an exaggerated inspiratory 
decrease in mitral valve inflow. This is an echocardiographic equivalent of pulsus 
paradox. Echocardiographically this has been described as interventricular 
interdependence and interpretated as exaggerated changes in mitral and tricuspid 
Doppler inflow and M mode finding of enhanced reciprocal changes in ventricular 
dimensions.9 
The physiology of a closed ECMO circuit is briefly reviewed for a better 
understanding of the hemodynamics of cardiac tamponade in patients with 
mechanical ventilator support. The V-A ECMO circuit withdraws deoxygenated 
blood from the right atrium or central vein with a non-pulsatile pump and directs it 
to the membrane oxygenator and then to a systemic artery via an outflow cannula, 
thus replacing the heart and lungs.1 As seen with this circuit, the physiology of 
interventricular interdependence is replaced by a mechanical non-pulsatile pump 
and oxygenator, therefore making the diagnosis of cardiac tamponade on the 
basis classical signs and symptoms of pulsus paradox and interventricular 
interdependence unreliable. 
The positive pressure ventilation is known to mask the pulsus paradoxus and in 
combination with ECMO support will further augment the masking of this 
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tamponade physiology. The LV Impella unloads the left ventricle and decreases 
the left ventricular end diastolic pressure, which intuitively should help in 
recognition of pulsus paradox. However, it also provides a continuous flow which 
masks any potential variability coming from the native left ventricular contractions. 
It is important to understand that cardiac output in a patient on MCS consists of 
two parts:  the support provided by the devices such as ECMO and Impella, and 
the output coming from the native heart. In our patient, who had a combined 
ECMO and Impella flow of 7 L/min, her own heart with a LVEF < 20% was only 
minimally contributing. 
The hemodynamic performance of the LV in cardiogenic shock is best described 
by pressure volume loop (PV loop). Independent of underlying etiology, the LV 
contractility (reflected by Emax and defined as the maximum slope at the end 
systolic PV point) is reduced and LV end diastolic pressure is increased.1 In this 
PV loop the exact hemodynamics on a patient on V-A ECMO, LV Impella, and 
mechanical ventilation has not been described before in our literature search. 
At the molecular level, the phenomena of myocardial stunning in myocarditis has 
been described and is implicated due to increased reactive oxygen species 
production, with a decreased sensitivity of myofilaments to calcium and 
dysfunction of excitation coupling phenomena.10 The immediate recovery of LV 
function after relief of pericardial tamponade in this patient may have some 
underlying stunning.  
Pericardial tamponade has been described in pediatric and adult ECMO patients. 
However, this is limited to a few case reports.11,12 Our case is unique, as 
pericardial tamponade in complex scenario such as the combined use of ECMO 
and Impella has not been described in the literature to our knowledge. 
 
Conclusion 
Several takeaway messages can be made from this case: 
1. The patient on ECPELLA circuit shows atypical features of cardiac 
tamponade. Classical signs of pulsus paradox and interventricular 
interdependence are absent, which can delay the diagnosis of pericardial 
tamponade if existing clinical, hemodynamic, and echocardiographic 
criteria are applied. 
2. Echocardiographically the use of Doppler criteria and inferior vena cava 
plethora can be misleading. The only findings could be demonstration of 
chamber invagination signs and large effusions with swinging motion which 
usually are seen late in the continuum of cardiac tamponade. 
3. Invasive hemodynamics using right heart catheter cannot be completely 
relied upon, in view of the altered physiology in the MCS. 
4. Limited echocardiography should be part of daily exams in patients on 
MSC, to assess the accumulation of pericardial fluid. The significant 
improvement in handheld devices can be utilized in intensive care unit 
settings as a standard protocol. 
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5. We recommend considering draining any substantial pericardial effusion in 
patients that are on advanced MCS. It is imperative to remember that the 
traditional signs of pericardial tamponade may not be reliable in patients 
supported on MCS. 
6. Further research is needed in animal or computer models to assess the 
effect of tamponade physiology on PV loop in patients on these devices, 
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